DNGFF(DNGFF)
DNGFF
No analyst ratings available
No analyst price targets available for DNGFF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $85.94B | $91.97B | $97.31B |
| Low | $78.66B | $71.44B | $82.13B |
| High | $89.92B | $105.99B | $107.13B |
| EBITDA Avg | $6.62B | $7.08B | $7.49B |
| Low | $6.06B | $5.50B | $6.33B |
| High | $6.93B | $8.16B | $8.25B |
| EBIT Avg | $5.24B | $5.61B | $5.94B |
| Low | $4.80B | $4.36B | $5.01B |
| High | $5.49B | $6.47B | $6.54B |
| Net Income Avg | $4.76B | $5.55B | $6.15B |
| Low | $3.80B | $4.43B | $4.90B |
| High | $5.39B | $6.28B | $6.95B |
| EPS Avg | $1.38 | $1.61 | $1.78 |
| Low | $1.10 | $1.28 | $1.42 |
| High | $1.56 | $1.82 | $2.01 |
| Analysts (Rev / EPS) | 12 / 1 | 13 / 1 | 8 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $19.60B | $29.75B | $23.93B | $29.26B | $22.88B | $34.73B |
| Low | $19.45B | $29.52B | $23.75B | $29.03B | $22.70B | $34.46B |
| High | $19.75B | $29.98B | $24.11B | $29.48B | $23.05B | $35.00B |
| EBITDA Avg | $1.51B | $2.29B | $1.84B | $2.25B | $1.76B | $2.67B |
| Low | $1.50B | $2.27B | $1.83B | $2.24B | $1.75B | $2.65B |
| High | $1.52B | $2.31B | $1.86B | $2.27B | $1.78B | $2.70B |
| EBIT Avg | $1.20B | $1.82B | $1.46B | $1.79B | $1.40B | $2.12B |
| Low | $1.19B | $1.80B | $1.45B | $1.77B | $1.39B | $2.10B |
| High | $1.21B | $1.83B | $1.47B | $1.80B | $1.41B | $2.14B |
| Net Income Avg | $1.32B | $1.21B | $1.83B | $1.03B | $1.62B | $1.09B |
| Low | $1.31B | $1.20B | $1.81B | $1.02B | $1.60B | $1.07B |
| High | $1.34B | $1.22B | $1.85B | $1.04B | $1.63B | $1.10B |
| EPS Avg | $0.38 | $0.35 | $0.53 | $0.30 | $0.47 | $0.31 |
| Low | $0.38 | $0.35 | $0.52 | $0.29 | $0.46 | $0.31 |
| High | $0.39 | $0.35 | $0.53 | $0.30 | $0.47 | $0.32 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |